Correlation Between Vitrolife and Cantargia
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Cantargia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Cantargia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Cantargia AB, you can compare the effects of market volatilities on Vitrolife and Cantargia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Cantargia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Cantargia.
Diversification Opportunities for Vitrolife and Cantargia
Poor diversification
The 3 months correlation between Vitrolife and Cantargia is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Cantargia AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cantargia AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Cantargia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cantargia AB has no effect on the direction of Vitrolife i.e., Vitrolife and Cantargia go up and down completely randomly.
Pair Corralation between Vitrolife and Cantargia
Assuming the 90 days trading horizon Vitrolife AB is expected to generate 0.36 times more return on investment than Cantargia. However, Vitrolife AB is 2.8 times less risky than Cantargia. It trades about -0.05 of its potential returns per unit of risk. Cantargia AB is currently generating about -0.17 per unit of risk. If you would invest 24,700 in Vitrolife AB on August 30, 2024 and sell it today you would lose (2,100) from holding Vitrolife AB or give up 8.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Vitrolife AB vs. Cantargia AB
Performance |
Timeline |
Vitrolife AB |
Cantargia AB |
Vitrolife and Cantargia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vitrolife and Cantargia
The main advantage of trading using opposite Vitrolife and Cantargia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Cantargia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cantargia will offset losses from the drop in Cantargia's long position.Vitrolife vs. Skandinaviska Enskilda Banken | Vitrolife vs. USWE Sports AB | Vitrolife vs. TF Bank AB | Vitrolife vs. Online Brands Nordic |
Cantargia vs. Hansa Biopharma AB | Cantargia vs. Oncopeptides AB | Cantargia vs. BioArctic AB | Cantargia vs. Alligator Bioscience AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |